A Review on Nanoparticle Enhanced Antibiotic Strategies Against Streptococcus Pneumoniae

Streptococcus pneumoniae is a major human pathogen causing severe diseases like pneumonia, meningitis, and sepsis. The rising resistance of S. pneumoniae to traditional antibiotics has instigated the development of novel therapeutic strategies. Nanotechnology has been identified as a potential solution, providing better drug delivery, improved bioavailability, and targeted antibacterial action. Nanoparticles such as gold nanoparticles (AuNPs) and polymer-based carriers have been found to hold promise in terms of enhancing antibiotic efficacy with reduced toxicity and the potential for resistance development. Nano systems allow for the controlled release of drugs, providing targeted higher drug concentrations in the site of infection and lowering systemic side effects. Even with these developments, studies are required for optimizing nanoparticle formulations, determining long-term safety, and deploying laboratory results in clinical settings. The future of nanotechnology applications for antimicrobial treatment is highly promising and may transform the treatment of S. pneumoniae infections.